Cancer Family
Intestinal Neoplasm
CI-CAN-00000209Explore in graph →
Non-malignant1,892 active trials21 approved drugs383 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000209Explore in graph →
Clinical trials
9,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06646809 | Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial(RISIS-CR) | unknown | Phase 3 | 80 | National University Hospital, SingaporeOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT02355379 | Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over(ADAGE) | unknown | Phase 3 | 774 | Federation Francophone de Cancerologie DigestiveOTHER |
| 1 |
| Jul 8, 2024 |
| clinicaltrials |
| NCT06139926 | Clinical Study of Dexmedetomidine Administered Intranasally to Relieve Perioperative Anxiety and Depression in Patients With Colorectal Tumors | unknown | Phase 3 | 126 | First Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT02102789 | A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis | unknown | Phase 3 | 142 | Yuhong LiOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT00565708 | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers(ASCOLT) | unknown | Phase 3 | 1,587 | National Cancer Centre, SingaporeOTHER | 10 | Feb 2, 2024 | clinicaltrials |
| NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | unknown | Phase 2 / Phase 3 | 1,194 | Alliance for Clinical Trials in OncologyOTHER | 4 | Feb 2, 2024 | clinicaltrials |
| NCT04338191 | mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer(FANTASTIC) | unknown | Phase 3 | 638 | Sun Yat-sen UniversityOTHER | 1 | Dec 27, 2023 | clinicaltrials |
| NCT05631041 | Effect of Silymarin in Metastatic Colorectal Cancer Patients | unknown | Phase 3 | 64 | Tanta UniversityOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT05081687 | Brazilian Total Neoadjuvant Therapy Trial(BRAZIL-TNT) | unknown | Phase 3 | 150 | Hospital Israelita Albert EinsteinOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT06017583 | Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer | unknown | Phase 3 | 48 | Yong Zhang,MDOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT00958737 | Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer(IDEA) | unknown | Phase 3 | 2,000 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT02614534 | Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma(HIPECT4) | unknown | Phase 3 | 200 | Maimónides Biomedical Research Institute of CórdobaOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT06049901 | Nitazoxanide in Patients With Metastatic Colorectal Cancer | unknown | Phase 3 | 60 | Tanta UniversityOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT02031939 | Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer | unknown | Phase 3 | 556 | Sun Yat-sen UniversityOTHER | 1 | Aug 25, 2023 | clinicaltrials |
| NCT04262635 | Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer(C-CLASSIC) | unknown | Phase 3 | 80 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2023 | clinicaltrials |
| NCT03950154 | Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer | unknown | Phase 3 | 198 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05948072 | Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM | unknown | Phase 3 | 250 | Fudan UniversityOTHER | 1 | Jul 17, 2023 | clinicaltrials |
| NCT04233151 | QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety | unknown | Phase 3 | 590 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 26, 2023 | clinicaltrials |
| NCT02288195 | CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients | unknown | Phase 3 | 663 | Sun Yat-sen UniversityOTHER | 1 | May 12, 2023 | clinicaltrials |
| NCT02974556 | Proactive Management of Endoperitoneal Spread in Colonic Cancer(PROMENADE) | unknown | Phase 3 | 140 | University of Roma La SapienzaOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT03391934 | Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer | unknown | Phase 3 | 234 | CinnagenINDUSTRY | 1 | Apr 5, 2023 | clinicaltrials |
| NCT05698082 | FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues | unknown | Phase 2 / Phase 3 | 120 | xiaoliang HuangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05540951 | VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer | unknown | Phase 3 | 78 | Fudan UniversityOTHER | 1 | Sep 15, 2022 | clinicaltrials |
| NCT05409417 | Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status | unknown | Phase 2 / Phase 3 | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT05378867 | A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC(CRC) | unknown | Phase 3 | 126 | Zhejiang Teruisi Pharmaceutical Inc.INDUSTRY | 0 | May 18, 2022 | clinicaltrials |
| NCT05374252 | Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients | unknown | Phase 3 | 102 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | May 16, 2022 | clinicaltrials |
| NCT05362617 | mFOLXOX6 Versus FOLFIRI for Colorectal Patients Recurrence After Oxaplatin Based Adjuvant Chemotherapy | unknown | Phase 3 | 328 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT05327751 | Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer(HFS) | unknown | Phase 3 | 44 | Tanta UniversityOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03957733 | Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients. | unknown | Phase 2 / Phase 3 | 338 | King Abdullah Medical CityOTHER_GOV | 1 | Apr 6, 2022 | clinicaltrials |
| NCT04167436 | Fit for Surgery. Multimodal Prehabilitation in Colorectal Cancer Patients | unknown | Phase 2 / Phase 3 | 48 | Zealand University HospitalOTHER | 1 | Mar 3, 2022 | clinicaltrials |
| NCT05187481 | Effect of Jianpi Huatan Decoction on Advanced Colorectal Cancer | unknown | Phase 3 | 200 | Xiyuan Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05079438 | Dendrobium Huoshanense Suppository in Rectal Cancer | unknown | Phase 3 | 168 | Zhejiang Cancer HospitalOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT05074966 | The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts | unknown | Phase 3 | 314 | Chinese Academy of Medical SciencesOTHER | 1 | Oct 12, 2021 | clinicaltrials |
| NCT04781270 | mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases | unknown | Phase 3 | 308 | Fudan UniversityOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT02533271 | Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer(STELLAR) | unknown | Phase 3 | 600 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04917289 | CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients | unknown | Phase 3 | 100 | Fudan UniversityOTHER | 0 | Jun 8, 2021 | clinicaltrials |
| NCT04912258 | Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis | unknown | Phase 3 | 80 | Fudan UniversityOTHER | 1 | Jun 3, 2021 | clinicaltrials |
| NCT02942706 | Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC | unknown | Phase 2 / Phase 3 | 200 | Ruijin HospitalOTHER | 0 | Apr 30, 2021 | clinicaltrials |
| NCT02526953 | Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients | unknown | Phase 3 | 314 | Blokhin's Russian Cancer Research CenterOTHER | 0 | Feb 9, 2021 | clinicaltrials |
| NCT04103697 | Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer(RuCorT-01) | unknown | Phase 3 | 560 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04134897 | Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer(RuCorT-02) | unknown | Phase 3 | 316 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04135313 | Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer(RuCorT-03) | unknown | Phase 3 | 540 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04712032 | Anastomotic Leakage and Value Of Indocyanine Green in Decreasing Leakage Rates(AVOID) | unknown | Phase 3 | 978 | Leiden University Medical CenterOTHER | 1 | Jan 15, 2021 | clinicaltrials |
| NCT03716518 | Herbal Treatment to Improve Chemotherapy Delivery(HATCHED) | unknown | Phase 3 | 400 | Xiyuan Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | Jan 12, 2021 | clinicaltrials |
| NCT04690283 | Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial(YWPPEOPNCT) | unknown | Phase 3 | 360 | Nanjing NingQi Medicine Science and Technology Co., Ltd.INDUSTRY | 0 | Dec 30, 2020 | clinicaltrials |
| NCT04642924 | SGM-101 in Locally Advanced and Recurrent Rectal Cancer(SGM-LARRC) | unknown | Phase 2 / Phase 3 | 203 | Leiden University Medical CenterOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT03909724 | Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC)(SUNRISE-CRC) | unknown | Phase 2 / Phase 3 | 60 | Amsterdam UMC, location VUmcOTHER | 1 | Nov 13, 2020 | clinicaltrials |
| NCT04552093 | Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT)(PUMP-IT) | unknown | Phase 2 / Phase 3 | 31 | The Netherlands Cancer InstituteOTHER | 1 | Sep 17, 2020 | clinicaltrials |
| NCT04525326 | Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases | unknown | Phase 3 | 584 | Fudan UniversityOTHER | 0 | Aug 25, 2020 | clinicaltrials |
| NCT04509635 | Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis | unknown | Phase 3 | 50 | Fudan UniversityOTHER | 0 | Aug 12, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Oct 17, 2024source: clinicaltrials